Has David Shaw received payments from drug or device companies?

Yes. Drug and device makers reported $2,141 in general payments to David Shaw across 126 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Shaw did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Shaw come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Shaw

Internal Medicine · Los Altos, CANPI 1609965235

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Romark Laboratories, LC at 35.5% of the total. Reporting peaked in 2021 at $665 and has fallen 97.9% since, to $14 in 2023.

$2,141in general payments, 2019–2025

Across 126 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Romark Laboratories, LC$761
AbbVie$487
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$211
Paratek Pharmaceuticals, Inc.$123
Merck$123
Nestle Healthcare Nutrition Inc.$111
plus $327 from 9 others

What the payments were for

Food & beverage$2,141100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Romark Laboratories, LC	45	$761
AbbVie(2 entities)	34	$487
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	12	$211
Paratek Pharmaceuticals, Inc.	6	$123
Merck	7	$123
Nestle Healthcare Nutrition Inc.	7	$111
Mayne Pharma Commercial LLC	4	$83
Biohaven Pharmaceuticals, Inc.	2	$52
Bio Products Laboratory USA, Inc.	2	$43
Teva Pharmaceuticals USA, Inc.	2	$32
Grifols USA, LLC	1	$30
Shire North American Group Inc	1	$27
Johnson & Johnson	1	$23
Amgen	1	$19
QOL Medical, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Alinia$375

How this compares

$2,141 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Los Altos

Andrew ChengSouth San Francisco$55.1M
Tung NgoNewport Beach$4.9M
Christian EversullStanford$2.9M
Christian SandrockSacramento$2.1M
Hatim HusainSan Diego$2M
Teck LingPalo Alto$1.1M
Hyong Kimla Jolla$1M
Rohit Loombala Jolla$965K
Fred CohenSan Francisco$929K
Steven EdelmanSan Diego$863K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →